Kadowaki; Tadashi

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kadowaki; Tadashi.The latest application filed is for "information processing device, regression model generation method, and regression model generation program product".

Company Profile

2.5.16

Kadowaki; Tadashi - Kariya-city JP
Kadowaki; Tadashi - Tsukuba JP
Kadowaki; Tadashi - Tsukuba-shi JP
Kadowaki; Tadashi - Ibaraki-Ken JP
Kadowaki; Tadashi - Osaka JP

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Information Processing Device, Regression Model Generation Method, And Regression Model Generation Program Product App 20210397923 - Kadowaki; Tadashi	2021-12-23
Information Processing Apparatus And Method And Program For Identifying Coadapted Nodes App 20210304046 - MIKI; Akira ; et al.	2021-09-30
Information Process Device, Data Decomposition Method, And Storage Medium Storing Data Decomposition Program App 20210295157 - KADOWAKI; TADASHI ; et al.	2021-09-23
Information Processing Apparatus And Method And Program For Generating Integrated Model App 20210124988 - KADOWAKI; Tadashi	2021-04-29
Method for Predicting Effectiveness of Angiogenesis Inhibitor App 20200199689 - Semba; Taro ; et al.	2020-06-25
Biomarkers for predicting and assessing responsiveness of endometrial cancer subjects to lenvatinib compounds Grant 10,517,861 - Funahashi , et al. Dec	2019-12-31
Biomarkers For Predicting And Assessing Responsiveness Of Thyroid And Kidney Cancer Subjects To Lenvatinib Compounds App 20180209980 - Funahashi; Yasuhiro ; et al.	2018-07-26
Biomarkers for a Combination Therapy Comprising Lenvatinib and Everolimus App 20180136216 - Funahashi; Yasuhiro ; et al.	2018-05-17
Biomarkers for predicting and assessing responsiveness of thyroid and kidney cancer subjects to lenvatinib compounds Grant 9,945,862 - Funahashi , et al. April 17, 2	2018-04-17
Method For Predicting Effectiveness Of Angiogenesis Inhibitor App 20170191137 - Semba; Taro ; et al.	2017-07-06
Biomarkers For Predicting And Assessing Responsiveness Of Endometrial Cancer Subjects To Lenvatinib Compounds App 20160089366 - Funahashi; Yasuhiro ; et al.	2016-03-31
Biomarkers For Predicting And Assessing Responsiveness Of Thyroid And Kidney Cancer Subjects To Lenvatinib Compounds App 20140187577 - Funahashi; Yasuhiro ; et al.	2014-07-03
Method For Predicting Effectiveness Of Angiogenesis Inhibitor App 20140148483 - Semba; Taro ; et al.	2014-05-29
Method For Assaying Action Of Antitumor Agent Using Decrease In Gene Expression Level As Index App 20100086931 - Mizui; Yoshiharu ; et al.	2010-04-08
Method For Assaying Action Of Antitumor Agent Using Splicing Defects As Index App 20100021918 - Mizui; Yoshiharu ; et al.	2010-01-28
Semiconductor device including a MISFET and a MIS capacitor Grant 7,259,418 - Kadowaki , et al. August 21, 2	2007-08-21
Semiconductor device and method for fabricating the same Grant 7,034,407 - Imade , et al. April 25, 2	2006-04-25
Semiconductor device and method for fabricating the same App 20050087818 - Imade, Masahiro ; et al.	2005-04-28
Semiconductor device and method for fabricating the same App 20050045888 - Kadowaki, Tadashi ; et al.	2005-03-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.